Latest

Politics Rachel Cohrs Zhang

Mark Cuban is pushing his anti-PBM agenda with Kamala Harris — and it’s working

Pharmalot Ed Silverman

STAT Plus: ViiV takes steps to widen access to HIV prevention drug, but continues to encounter criticism

Politics Rachel Cohrs Zhang and John Wilkerson

STAT Plus: Harris seeks to tie expanded Medicare drug price negotiation to home care, vision, hearing coverage expansion

Pharmalot Ed Silverman

STAT Plus: U.S. Supreme Court asks solicitor general for views on controversial Oklahoma law for regulating PBMs

Health Tech Newsletter Mohana Ravindranath

Otsuka, Amalgam partner on Alzheimer’s care tech; Hello Heart joins Amwell’s telehealth network

Pharmalot Ed Silverman

STAT Plus: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

Exclusive Allison DeAngelis

STAT Plus: Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup

In the Lab Andrew Joseph

2024 Nobel Prize winners: Physics award goes to Hopfield, Hinton for machine learning discoveries

Exclusive Megan Molteni

STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur

Health Timmy Broderick

Q&A: Why the NIH is spending $30 million to counter ableism in health care

First Opinion Rick A. Bright

Trump’s dangerous Covid-19 revisionism

Health tech Mario Aguilar

STAT Plus: Biogen turns to telehealth company to boost its postpartum depression drug

Health Care Brittany Trang

White House should declare national emergency over IV fluid shortages caused by Helene, says hospital group

Health Helen Branswell

Q&A: How California, now an epicenter for bird flu in dairy cattle, is monitoring the virus

In the Lab Anil Oza

2024 Nobel Prize winner Gary Ruvkun on sharing credit and the future of microRNA

Exclusive Matthew Herper

STAT Plus: Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs

Health Jonathan Wosen

Wealthy nations might be reaching a life expectancy limit, study suggests — at least for now

Biotech Elaine Chen

STAT Plus: Scholar Rock drug for spinal muscular atrophy succeeds in late-stage study

Exclusive Isabella Cueto

With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit

In the Lab Andrew Joseph

2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA

First Opinion Miranda Wolpert

A global revolution in funding mental health care is coming

Who to Know Brian Yang

STAT Plus: 12 people changing the course of the Chinese biopharma industry

Health Eric Boodman

Sammy Basso, progeria advocate, has died at 28

First Opinion Laura and John Arnold

STAT Plus: Philanthropists Laura and John Arnold warn: Beware hospital consolidation

Letters to the editor Torie Bosch

First Opinion readers on Hatch-Waxman, new-patient visit times, mpox, and more

Health Helen Branswell

Rwanda to receive experimental vaccines, therapeutics to combat Marburg outbreak

Politics Rachel Cohrs Zhang

STAT Plus: Trump backs off proposal to slash prescription drug prices by linking them to foreign countries

Biotech Jonathan Wosen

STAT Plus: Exact Sciences wins FDA approval for improved stool-based colon cancer test

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings